NEWS

Senti Biosciences Announces Curt Herberts as New Chief Financial Officer and Chief Business Officer – Press of Atlantic City

Senti Biosciences Announces Curt Herberts as New Chief Financial Officer and Chief Business OfficerPress of Atlantic CityBiosciences, the leading synthetic biology company developing. next-generation adaptive therapies for patients living with serious,… Continue reading

Global Gene Therapy Market Forecast to 2020 with Focus on the United States – GlobeNewswire (press release)

afinancialanalysis.comGlobal Gene Therapy Market Forecast to 2020 with Focus on the United StatesGlobeNewswire (press release)"Global & US Gene Therapy Market Forecast to 2020, most of the gene therapy researches are being focused on finding t… Continue reading

What Is Immunotherapy?: Woman With Terminal Breast Cancer Saved by Pioneering Treatment – Newsweek

Senti Biosciences Announces Curt Herberts as New Chief Financial Officer and Chief Business Officer – PR Newswire (press release)

Senti Biosciences Announces Curt Herberts as New Chief Financial Officer and Chief Business OfficerPR Newswire (press release)SOUTH SAN FRANCISCO, Calif., June 5, 2018 /PRNewswire/ — Senti Biosciences, the leading synthetic biology company developing … Continue reading

International Stem Cell Corporation to Launch Advanced Joint Supplement – GlobeNewswire (press release)

International Stem Cell Corporation to Launch Advanced Joint SupplementGlobeNewswire (press release)CARLSBAD, Calif., June 05, 2018 (GLOBE NEWSWIRE) — International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) ("ISCO" o… Continue reading

Buy These 2 Biotech Stocks on the Dip After an FDA Delay — The … – Motley Fool

Investorplace.comBuy These 2 Biotech Stocks on the Dip After an FDA Delay — The …Motley FoolThere are two words that no biotech likes to hear: clinical hold. Unfortunately, Vertex Pharmaceuticals (NASDAQ:VRTX) and CRISPR Therapeutics …CRISPR … Continue reading

Immunotherapy Clinical Trial at Overlook Medical Center Reveals Brain Tumor Shrinkage, Continues with Phase 3 Study – TAPinto.net

TAPinto.netImmunotherapy Clinical Trial at Overlook Medical Center Reveals Brain Tumor Shrinkage, Continues with Phase 3 StudyTAPinto.netSUMMIT, NJ – Following successful Phase 1 clinical trials, the Toca regimen – a new immunotherapy for patients with… Continue reading